Efficacy and Safety of Tacrolimus in Children with Refractory Nephrotic Syndrome

被引:0
|
作者
Jiang, X. Y. [1 ]
Lin, R. H. [1 ]
Chen, L. Z. [1 ]
Ling, Y. H. [1 ]
Mo, Y. [1 ]
机构
[1] Sun Yat Sen Univ, Guangzhou 510275, Guangdong, Peoples R China
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
52
引用
收藏
页码:1805 / 1805
页数:1
相关论文
共 50 条
  • [31] The efficacy and safety of rituximab in treating childhood refractory nephrotic syndrome: A meta-analysis
    Zhihong Zhao
    Guixiang Liao
    Yongqiang Li
    Shulu Zhou
    Hequn Zou
    Scientific Reports, 5
  • [32] Efficacy and Safety of PCSK9 Inhibitors in Hypercholesterolemia Associated With Refractory Nephrotic Syndrome
    Jatem, Elias
    Lima, Joan
    Montoro, Bruno
    Torres-Bondia, Francisco
    Segarra, Alfons
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (01): : 101 - 109
  • [33] The efficacy and safety of rituximab in treating childhood refractory nephrotic syndrome: A meta-analysis
    Zhao, Zhihong
    Liao, Guixiang
    Li, Yongqiang
    Zhou, Shulu
    Zou, Hequn
    SCIENTIFIC REPORTS, 2015, 5
  • [34] Tacrolimus for Children with Refractory Nephrotic Syndrome: A 1 year Prospective, Multicenter, Open-Label Study
    Park, Hye Won
    Kang, Hee Gyung
    Yang, Eun Mi
    Cheong, Hae Il
    Choi, Yong
    Ha, Il Soo
    PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1605 - 1605
  • [35] Efficacy of tacrolimus in patients with cortico-resistant nephrotic syndrome
    Liern, Miguel
    Vallejo, Graciela
    REVISTA DE NEFROLOGIA DIALISIS Y TRASPLANTE, 2008, 28 (02): : 61 - 64
  • [36] Tachyphylaxis to Cyclosporin A in Children with Refractory Nephrotic Syndrome
    Kaku, Yoshitsugu
    WataruShimabukuro
    Kei
    Noshiyama
    KazunaEjima
    Ohta, Yuko
    Naoko
    Itoh
    Kuroki, Rie
    Kodama, Shiho
    PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1614 - 1614
  • [37] TREATMENT OF REFRACTORY NEPHROTIC SYNDROME IN CHILDREN WITH CYCLOSPORINE
    COHEN, MAH
    LUM, GM
    FORD, DM
    KIDNEY INTERNATIONAL, 1990, 37 (01) : 255 - 255
  • [38] Meta-analysis on the efficacy and safety of rituximab versus tacrolimus for nephrotic syndrome in the paediatric age group
    Rehan, Syeda Tayyaba
    Ali, Eman
    Eqbal, Farea
    Ahsan, Muhammad Nadeem
    Asghar, Muhammad Sohaib
    CLINICAL KIDNEY JOURNAL, 2024, 17 (01)
  • [39] The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy
    Liang, Qian
    Li, Heng
    Xie, Xishao
    Qu, Fangzhi
    Li, Xiayu
    Chen, Jianghua
    RENAL FAILURE, 2017, 39 (01) : 512 - 518
  • [40] Efficacy of rituximab therapy in children with refractory nephrotic syndrome: a prospective observational study in Shanghai
    Sun, Li
    Xu, Hong
    Shen, Qian
    Cao, Qi
    Rao, Jia
    Liu, Hai-Mei
    Fang, Xiao-Yan
    Zhou, Li-Jun
    WORLD JOURNAL OF PEDIATRICS, 2014, 10 (01) : 59 - 63